Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCR-002 phase 2b study in acute hepatic encephalopathy
2013-005412-10Phase 2Completed
- Sponsor
- Ocera Therapeutics
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ornithine phenylacetate in hepatic encephalopathy (HE) (2 arms), sponsored by Ocera Therapeutics. Started Jun 2014; status: completed.
02
Drugs
ornithine phenylacetate
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on 2013-005412-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005412-10.